Younis Husam bought RNA
April 20, 2026 · Form 4 insider transaction
Younis Husam bought 30,000 shares of Atrium Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
30,000
Price
$0.00
Total value
N/A
InsiderYounis Husam
RoleOfficer
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateApril 20, 2026
Filing dateApril 22, 2026
Shares owned after52,657
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents an award of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Twenty-five percent (25%) of the RSUs shall vest on March 20, 2027, with the remaining RSUs vesting in three (3) substantially equal yearly installments each year thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date.